(Shanghai, China, September 2, 2021) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharmaceutical" or "Group", stock code: 600196.SH, 02196.HK) announced that on September 2, Fosun Pharma supplied the first batch of mRNA new crown vaccine Fubitai (ie BNT162b2) produced by BioNTech in Taiwan from Europe to Taoyuan Airport in Taiwan, and the first batch arrived at 932,000 doses. The vaccine will be donated by private organizations in Taiwan for inoculation of Taiwan compatriots. It is suitable for active immunization of teenagers and adults over 12 years old to prevent diseases caused by new coronavirus infection.